Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 21. Click on ID to see further detail.
IDOV_2710Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result90% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2711Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result85% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2712Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result85% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2713Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration50 MOIIn-vitro result80% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2714Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration100 MOIIn-vitro result70% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2715Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration200 MOIIn-vitro result60% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2716Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (0.1 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result90% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2717Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (1 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result70% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2718Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (5 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result60% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2719Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (10 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2720Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration5 MOIIn-vitro result40% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2721Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result90% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2722Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result70% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2723Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2724Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2725Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration10 MOIIn-vitro result40% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2726Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result90% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2727Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result70% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2728Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2729Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819
IDOV_2730Virus nameAdenovirusVirus strainSG600Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationDeletion of E1A, E1B promoter and E1ACR2 regionVirus aloneNoVirus in combination with drug/radiationVirus strain in combination with vincristine (50 nm)Immune gene insertion in viral genomeNoSource of cell lineCentral south university,ChinaOrigin of cell lineHuman retinoblastoma cell lineCell lineHXO-RB44Concentration of cell lineNAIn-vitro toxicityNAAssaycell proliferation kit analysisIn-vitro virus concentration20 MOIIn-vitro result40% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedS-phase arrest and induction of apotosisImmunogenic effectDownregulation of Akt pathwayClinical trialNAPMID23109819